FindTrial
Sign In

Establish and validate a prognostic model for overall survival of bladder neuroendocrine carcinoma based on clinical treatment data

Establish and validate a prognostic model for overall survival of bladder neuroendocrine carcinoma based on clinical treatment data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107241
Enrollment
Unknown
Registered
2025-08-06
Start date
2025-08-31
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuroendocrine bladder cancer

Interventions

Training group:None
Validation group:None

Sponsors

Chongqing Emergency Medical Center (Chongqing Fourth People's Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: All the patients were >= 20 years, pathologically diagnosed with primary NEBC from 2004 to 2015.

Exclusion criteria

Exclusion criteria: 1. Tis; 2.survival time less than 1 month or unknown; 3.information unknown such as race, marital status, TNM stage and surgery.

Design outcomes

Primary

MeasureTime frame
overall survival;—

Countries

China

Contacts

Public ContactLiang Liu

Chongqing Emergency Medical Center (Chongqing Fourth People's Hospital)

mnwkll@163.com+86 23 6369 2122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026